methylprednisolone has been researched along with Devic Disease in 157 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 28 (17.83) | 29.6817 |
2010's | 102 (64.97) | 24.3611 |
2020's | 27 (17.20) | 2.80 |
Authors | Studies |
---|---|
Lei, J; Wang, H | 1 |
Du, C; Han, JR; Jia, D; Shi, FD; Zeng, P; Zhang, C; Zhang, TX | 1 |
Guo, S; Jiang, H; Jiang, L; Liu, H; Peng, J; Wang, J; Wei, W | 1 |
Jang, Y; Jung, JH; Kim, SJ; Kim, SM; Lee, HJ; Moon, Y | 1 |
Hansel, G; Mora Cuervo, DL; Sato, DK | 1 |
Castañeda, MRRQ; Espiritu, AI; Tan, MA | 1 |
Castillo Rocha, PA; Hon, KLE; López-Benítez, J; Mohanty, M; Torres, AR | 1 |
Chen, X; Jia, D; Lee, M; Peng, Y; Qi, J; Qiu, W; Quan, C; Shi, F; Wang, H; Wang, Y; Yang, H; Zeng, Q; ZhangBao, J; Zhong, X | 1 |
Cai, S; Guo, R; Jia, Z; Li, B; Liu, X; Sun, Y; Yuan, C; Zhang, L | 1 |
Khan, AH; Mahmud, R; Moniruzzaman, M; Rahman, MM; Sayeed, SKJB | 1 |
Al Othman, B; Kini, A; Lee, AG; Wang, R | 1 |
Iio, K; Kawada, N; Odachi, K; Tomimoto, H; Uno, K | 1 |
Prayoonwiwat, N; Siritho, S; Veerachit-O-Larn, T | 1 |
D, S; Kadhiravan, T; Moulitej, MMV; Pranov, R; Ramesh, A; Thabah, MM | 1 |
Jitprapaikulsan, J; Kittisares, K; Prayoonwiwat, N; Sathukitchai, C; Siritho, S; Songthammawat, T; Srisupa-Olan, T | 1 |
Kanbayashi, T; Sonoo, M; Tanaka, S | 1 |
Li, J; Li, M; Su, J; Wang, Q; Wang, Y; Wang, Z; Wu, DI; Xu, D; Zeng, X; Zhang, S; Zhao, J | 1 |
Benito-León, J; Dubey, S; Ghosh, R; Pandit, A; Purkait, S; Ray, BK | 1 |
Gao, YL; Guo, JJ; Wang, M; Wang, ZY; Yu, XF | 1 |
Nopsopon, T; Pongpirul, K; Siritho, S | 1 |
Chan, KH; Vorobeychik, G | 1 |
Huang, X; Wu, J; Xiao, Y; Zhang, Y | 1 |
Duan, Y; Li, X; Liu, Y; Ren, Y; Tian, DC; Wang, X; Xu, W; Xu, Y; Zhang, X | 1 |
Li, J; Li, X; Lin, J; Lin, Y; Pan, J; Xia, J; Xue, B; Zhu, R | 1 |
Chang, Y; Chu, M; Hu, X; Li, C; Li, R; Ling, L; Liu, X; Qiu, W; Wang, J; Wang, X; Wang, Y; Yang, H; Yu, B | 1 |
Hayashi, Y; Inuzuka, T; Kimura, A; Shibata, H; Shimohata, T; Ueda, N; Yaguchi, T; Yamada, M; Yoshikura, N | 1 |
Hemingway, C; Lim, M; Luchesa Smith, A; Sudarsan, N | 1 |
Fernández, Ó; Luetic, GG; Menichini, ML | 1 |
Belal, S; Ben Sassi, S; Douma, B; Jeridi, C; Nabli, F; Rachdi, A; Saied, Z | 1 |
Hao, X; Tang, H; Wang, L; Zhou, H | 1 |
Manners, J; Marker, D; Mettenburg, J; Murdoch, G; Stevens, B; Thomas, DL; Wang, G; Wiley, C | 1 |
Levin, MH | 1 |
Doi, K; Kageyama, T; Kambe, D; Maruyama, H; Ogawa, K; Suenaga, T; Takeoka, K; Yoshida, A | 1 |
Chan, K; Chesser, M; Kharidi, V; Puri, A | 1 |
Reich, SG; Smedley, AD; Snyder, A | 1 |
Bonnan, M; Cabre, P; Debeugny, S; Fergé, JL; Mehdaoui, H; Merle, H; Valentino, R | 1 |
Ikeda, Y; Kato-Motozaki, Y; Machiya, T; Muroishi, T; Sakai, K; Samuraki, M; Yamada, M; Yanase, D | 1 |
Río, J; Rodríguez-Acevedo, B | 1 |
Asano, T; Doi, H; Higashiyama, Y; Koyano, S; Takahashi, K; Takeuchi, H; Tanaka, F | 1 |
Kou, G; Li, Y; Zhang, Y | 1 |
E, RF; Qi, JL; Su, HJ; Wang, L; Zhao, K | 1 |
Hu, X; Xia, P; Zhou, H | 1 |
Estiasari, R; Imran, D; Kusumadewi, W; Maharani, K; Marwadhani, SS; Pakasi, TA; Pangeran, D; Rusmana, AI; Witjaksono, F | 1 |
Campbell, A; Ogundipe, OA | 1 |
Bian, X; Dong, E; Li, M; Liu, G; Liu, Z; Lou, X; Ma, L; Tang, Z; Tian, J; Tian, Y; Wang, Y; Wei, S | 1 |
Bennji, S; Brey, N; Koegelenberg, C; Sagar, D | 1 |
Kikumoto, M; Nonaka, M; Ohshita, T; Takeshita, J; Yamashita, H | 1 |
Chen, X; Li, W; Ma, H; Qin, L; Wang, F; Wang, X; Zhu, C | 1 |
Abdulhakeem, Z; El Moutawakil, B; El Otmani, H; Rafai, MA | 1 |
Chandorkar, N; Jain, R; Raj, D; Sharma, S; Vohra, P | 1 |
Jiao, L; Ling, F; Lu, J; Ma, Y; Wang, X; Zhang, H | 1 |
Levy, M; Mealy, MA | 1 |
Maruo, Y; Nakamura, M; Nishimura, H; Sakushima, K; Sasaki, H; Takahashi, I; Takahashi, T; Tsuzaka, K; Yabe, I; Yaguchi, H; Yashima-Yamada, M | 1 |
Chen, X; Cheng, C; Dai, Y; Hu, X; Jiang, Y; Kang, Z; Lu, Z; Peng, F | 1 |
Kvistad, SA; Myhr, KM; Torkildsen, Ø; Vedeler, CA; Wergeland, S | 1 |
Bai, YJ; Jiang, DX; Liao, Y | 1 |
Hyun, JW; Joo, J; Kim, HJ; Kim, SH; Park, B; Zandoná, ME | 1 |
Amjad, F; Ghavami, F; Gratton, S; Mora, C; Osborne, B; Tornatore, C | 1 |
Fujita, K; Izumi, Y; Kaji, R; Kanbayashi, T; Matsui, N; Nishida, Y; Sakai, W; Takahashi, T | 1 |
Hatanaka, Y; Matsumura, K; Okuma, H; Saito, F; Sonoo, M | 1 |
Asgari, N; Henriksen, TB; Lillevang, ST; Petersen, T; Weinshenker, BG | 1 |
Aoki, M; Fujihara, K; Ikeda, K; Kiyota, N; Kuroda, H; Misu, T; Nakashima, I; Nishiyama, S; Sato, DK; Takahashi, T | 1 |
Illes, Z; Nielsen, HH; Ravnborg, M | 1 |
Borazanci, A; Chang, GQ; Fu, Y; Li, YJ; Qi, Y; Shen, Y; Shi, FD; Su, L; Sun, N; Yan, Y; Yang, C; Zhang, F | 1 |
Asayama, S; Fujita, K; Kaneko, S; Koda, A; Kusaka, H | 1 |
Mohd Slim, MA; Schepel, J | 1 |
Miyamoto, K | 1 |
Marignier, R; Vukusic, S | 1 |
Cai, T; Lu, C; Lu, J; Qiao, J; Quan, C; Wang, B; Yu, H; ZhangBao, J; Zhao, C | 1 |
Abboud, H; Levy, M; Mealy, M; Petrak, A; Sasidharan, S; Siddique, L | 1 |
Annunziata, P; Arrigucci, U; Cerase, A; Cioni, C; Masi, G | 1 |
Changhong, D; Chunhong, C; Fang, F; Haitao, R; Jiuwei, L; Junlan, L; Liying, C; Weihua, Z; Xiaotun, R; Xinying, Y; Yun, W | 1 |
Kavoussi, SC; Lesser, RL | 1 |
Cocuzza, S; Di Mauro, P; Falsaperla, R; Ledda, C; Lubrano, R; Matin, N; Pavone, P; Serra, A; Tabatabaie, O; Vitaliti, G | 1 |
Adamu, MD; Balarabe, SA; Jiya, N; Watila, MM | 1 |
Altintas, A; Balci, BP; Boz, C; Celebisoy, N; Celik, Y; Colpak Isikay, I; Diker, S; Duman, T; Gokcay, F; Gozubatik Celik, G; Isik, N; Kansu, T; Karabudak, R; Mangan, MS; Nalbantoglu, M; Saip, S; Siva, A; Soysal, A; Terzi, M; Tuncer Kurne, A; Uygunoglu, U; Yucesan, C | 1 |
Bhatty, SA; Lal, H; Mahmood, K; Naqvi, I; Talib, A; Zaidi, SS | 1 |
Fujihara, K; Fukaura, H; Fukazawa, T; Kaida, K; Kanda, T; Kawachi, I; Kira, J; Matsui, M; Matsushita, T; Miyamoto, K; Mizusawa, H; Murai, H; Nagaishi, A; Nakatsuji, Y; Niino, M; Nomura, K; Ochi, H; Ogino, M; Ohashi, T; Tanaka, M; Togo, K; Tomioka, R; Yamasaki, R; Yokota, T; Yokoyama, K | 1 |
Cheng, HL; Lin, YX; Zhou, Y; Zhu, L | 1 |
Miranda, MJ; Olofsson, IA; Skov, L | 1 |
Blitz, AM; Graf, OW; Halfpenny, AM; Lin, AY; Lipton, HL; Moss, HE; Stroup, TS; Valyi-Nagy, T | 1 |
Cheuret, E; Garnier, A; Jacquet, C | 1 |
Davila-Acosta, J; Pohl, D; Thulasirajah, S; Venkateswaran, S | 1 |
Lu, J; Quan, C; Xi, J; ZhangBao, J; Zhao, C; Zhou, L | 1 |
Janow, GL; Kimura, Y; Kornitzer, JM | 1 |
Banwell, B; Narula, S | 1 |
Chen, Z; Huang, X; Huang, Y; Li, X; Lin, J; Pang, W; Quan, W; Xia, J; Xue, B | 1 |
Fujihara, K; Nakamura, S; Oshiro, A; Tamashiro, K | 1 |
Altintas, A; Ansari, B; Naser Moghadasi, A; Okhovat, AA; Rezaali, S | 1 |
Jin, X; Li, X; Liu, Y; Pei, S | 1 |
Hayashi, N; Suda, M; Tsutsumiuchi, M; Uesaka, Y | 1 |
Canales P, F; Gutiérrez O, C; Suárez H, F; Urrutia E, D | 1 |
Carnero Contentti, E; Di Pace, JL; Diego, A; Hryb, JP; Perassolo, M | 1 |
Furukawa, T; Izumi, Y; Kaji, R; Matsui, N; Tanaka, K | 1 |
Ao, R; Dong, Z; Ran, Y; Wang, L; Yu, S; Zhang, F | 1 |
Fryer, JP; Homburger, H; Hunter, J; Krecke, K; Kuntz, NL; Lennon, VA; Lotze, T; Lucchinetti, CF; McKeon, A; Ness, JM; Pittock, SJ; Rensel, M; Tenenbaum, S; Weinshenker, BG | 1 |
Fujihara, K; Itoyama, Y; Izumiyama, M; Misu, T; Takahashi, T; Takano, R | 1 |
Hunter, JV; Hutton, GJ; Lotze, TE; Northrop, JL; Ross, B; Schiffman, JS | 1 |
Anlar, B; Cakmakli, G; Güven, A; Kurne, A; Serdaroğlu, A; Teber, S; Topaloğlu, H | 1 |
Kalabrić-Lepur, N; Lepur, D; Peterković, V | 1 |
Bendtson, I; Pedersen, H; Trautner, S | 1 |
Fujishima, K; Fukae, J; Hattori, N; Noda, K; Okuma, Y; Takahashi, T; Tomizawa, Y; Yokoyama, K | 1 |
Kantarci, OH; Lennon, VA; Lucchinetti, CF; Magaña, SM; Matiello, M; McKeon, A; Pittock, SJ; Rabinstein, AA; Shuster, E; Weinshenker, BG | 1 |
Baba, T; Fujihara, K; Itoyama, Y; Kanbayashi, T; Konno, M; Misu, T; Nakashima, I; Ogawa, H; Shiga, Y; Takahashi, T; Takeda, A | 1 |
Aoki, M; Fujihara, K; Ito, T; Itoyama, Y; Jin, K; Kikuchi, A; Misu, T; Nishiyama, S; Suzuki, N; Takahashi, T | 1 |
Caniatti, L; De Gennaro, R; De Santis, G; De Vito, A; Granieri, E; Tola, MR | 1 |
Basic, S; Hajnsek, S; Nankovic, S; Pavlisa, G; Petelin Gadze, Z; Sporis, D | 1 |
Baig, F; Matthews, LA; Palace, J; Turner, MR | 1 |
Saida, T | 1 |
Brett, D; Kundi, S; Padmanabhan, R; Rabadi, MH | 1 |
Modderman, P; Riphagen, J; Verrips, A | 1 |
Imbe, H; Ito, T; Kitaoka, H; Nakajima, H | 1 |
Doi, H; Fujihara, K; Hariya, T; Misu, T; Nakamura, M; Nakazawa, T; Nishida, K; Omodaka, K; Takahashi, T | 1 |
Boggild, M; Clanet, M; Du Pasquier, RA; Hemmer, B; Hintzen, RQ; Illes, Z; Montalban, X; Polman, CH; Sellner, J; Sorensen, PS | 1 |
Molina, RM; Navarra, SV; Soldevilla, HF | 1 |
Bonnan, M; Cabre, P; Merle, H; Olindo, S; Signate, A; Smadja, D | 1 |
Fujihara, K; Itoyama, Y; Misu, T; Sato, S; Takahashi, T; Takano, R | 1 |
Fujiwara, Y; Isayama, R; Nakagawa, M; Shiga, K; Tanaka, A; Tanaka, K; Yamada, K; Yamada, T; Yoshida, T | 1 |
Ogasawara, M; Sakai, T; Shikishima, K; Takagi, M; Tanaka, K | 1 |
Kim, JS; Kim, SH; Kim, SM; Lee, KW; Park, KS; Park, YH; Sung, JJ | 1 |
Ochi, H | 1 |
Alberici, E; Bergamaschi, R; Caporali, R; Ceroni, M; Franciotta, D; Marchioni, E; Piccolo, G; Piccolo, L; Romani, A; Zardini, E | 1 |
de Andrés Frutos, C; García Domínguez, JM; Guzmán-de-Villoria, J; Martín-Barriga, ML; Martínez Ginés, ML; Muñoz Blanco, JL | 1 |
Ahtoy, P; Bourre, B; Hannequin, D; Lefaucheur, R; Maltête, D; Ozkul, O; Tollard, E | 1 |
Hirayama, T; Ikeda, K; Ito, H; Iwasaki, Y; Kano, O; Kawabe, K; Nakamura, Y; Yoshii, Y | 1 |
Ashida, A; Fukui, M; Shimakawa, S; Takahashi, T; Tamai, H | 1 |
Aktas, O; Bergh, FT; Berthele, A; Boettcher, T; Brettschneider, J; Ettrich, B; Faiss, JH; Geis, C; Guthke, K; Hartung, HP; Hellwig, K; Hemmer, B; Hoffmann, F; Hofstadt-van Oy, U; Jarius, S; Kern, P; Kleinschnitz, C; Kleiter, I; Kuempfel, T; Langel, S; Lauda, F; Liebetrau, M; Linker, RA; Marziniak, M; Mayer, CA; Melms, A; Metz, I; Münch, C; Neuhaus, O; Niehaus, S; Paul, F; Pellkofer, H; Reuss, R; Ringelstein, M; Rommer, PS; Ruprecht, K; Schippling, S; Sieb, JP; Stangel, M; Trebst, C; Tumani, H; Veauthier, C; Wandinger, KP; Wildemann, B; Wilke, C; Winkelmann, A; Zentner, C; Zettl U, UK; Ziemann, U | 1 |
Kawai, Y; Matsumoto, K; Miyamura, M; Nakanishi, H; Takahashi, Y; Yamasaki, M | 1 |
Stübgen, JP | 1 |
Ortega, MR; Rammohan, KW; Tornes, L | 1 |
McGraw, CA; Robbins, MS; Swerdlow, ML | 1 |
Cerghet, M; Farhat, E; Lim, HW; Salazar, R | 1 |
Aktas, O; Berthele, A; Cree, B; Hartung, HP; Hemmer, B; Kalluri, SR; Kieseier, BC; Menge, T; Methner, A; Saleh, A; Waterboer, T | 1 |
Cabot, F; Cabre, P; Donnio, A; Hage, R; Jeannin, S; Mehdaoui, H; Merle, H; Olindo, S; Richer, R; Smadja, D; Valentino, R | 1 |
Bichuetti, DB; Boulos, Fde C; Gabbai, AA; Oliveira, EM | 1 |
Parperis, K | 1 |
Azmat, Z; Hashmi, M; Mustafa, S; Siddiqi, SA; Siddiqui, KA | 1 |
Blackwood, E; Cordato, DJ; Dias, M; Griffith, NC; Patel, V | 1 |
Fujihara, K; Ichihashi, J; Inada, R; Kitada, M; Kusunoki, S; Mitsui, Y; Miyamoto, K; Suzuki, H; Takahashi, T | 1 |
Au, LW; Chan, AY; Fan, FS; Ip, VH; Lau, AY; Mok, VC; Wong, KS | 1 |
Cabre, P; Jeannin, S; Marignier, R; Merle, H; Olindo, S; Smadja, D | 1 |
Foroughipour, M; Nikbin, Z; Pezeshki Rad, M; Sahebari, M; Shoeibi, A | 1 |
Nakashima, I | 1 |
Amano, N; Joko, T | 1 |
Garssen, MP; Hintzen, RQ; Neuteboom, RF | 1 |
Jubelt, B; Mihai, C | 1 |
Bähr, M; Brück, W; Chan, A; Gärtner, J; Gold, R; König, FB; Koziolek, M; Linker, RA; Müller, GA; Paulus, W; Schilling, S | 1 |
Hamaguchi, T; Komai, K; Nozaki, I; Yamada, M | 1 |
Bernard, TJ; Corboy, JR; Hudson, LA; Miller, BR; Tseng, BS | 1 |
Dias Borges, A; Fernandes Adorno, L; Miranda de Sousa, A; Papais Alvarenga, M; Papais Alvarenga, RM; Puccioni-Sohler, M | 1 |
Fujihara, K; Itoyama, Y; Misu, T; Miyazawa, I; Nakashima, I; Shiga, Y; Watanabe, S | 1 |
Fujihara, K; Fujimori, J; Itoyama, Y; Kanaoka, C; Misu, T; Miyazawa, I; Nakamura, M; Nakashima, I; Sato, S; Shiga, Y; Takahashi, T; Watanabe, S | 1 |
Bergamaschi, R; Bogdanov, EI; Mikhaylov, IM; Moglia, A; Pichiecchio, A; Ravaglia, S | 1 |
Honda, K; Yuasa, T | 1 |
Ii, Y; Kuzuhara, S; Naito, Y; Sasaki, R; Shindo, A; Tanaka, K | 1 |
Cybulska, B; Juryńczyk, J; Sempińska-Szewczyk, J; Weglewski, A | 1 |
Foley-Nolan, D; Gibbs, AN; Moroney, J; O'Connell, PG | 1 |
24 review(s) available for methylprednisolone and Devic Disease
Article | Year |
---|---|
Immunobiology of neuromyelitis optica spectrum disorders.
Topics: Autoantibodies; Cytokines; Humans; Immunoglobulin G; Methylprednisolone; Neuromyelitis Optica | 2022 |
[Pediatric therapeutic options in autoimmune neurologic diseases].
Topics: Autoimmune Diseases; Child; Encephalomyelitis, Acute Disseminated; Humans; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica | 2022 |
[A case of suspected neuromyelitis optica spectrum disorder preceded by aseptic meningitis-like symptoms].
Topics: Adult; Brain; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Female; Humans; Meningitis, Aseptic; Methylprednisolone; Neuromyelitis Optica; Pulse Therapy, Drug; Spinal Cord; Treatment Outcome; Young Adult | 2019 |
Therapeutic plasma exchange vs conventional treatment with intravenous high dose steroid for neuromyelitis optica spectrum disorders (NMOSD): a systematic review and meta-analysis.
Topics: Administration, Intravenous; Humans; Methylprednisolone; Neuromyelitis Optica; Plasma Exchange; Visual Acuity | 2021 |
Timing of plasma exchange for neuromyelitis optica spectrum disorders: A meta-analysis.
Topics: Humans; Methylprednisolone; Neuromyelitis Optica; Plasma Exchange; Spinal Cord | 2021 |
Diagnosis and management of multiple sclerosis and other relapsing demyelinating disease in childhood.
Topics: Adolescent; Anti-Inflammatory Agents; Brain; Child; Demyelinating Diseases; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Neuromyelitis Optica; Occupational Therapy; Recurrence | 2022 |
Advances in Neuromyelitis Optica: Take Them to the Clinic.
Topics: Antibodies, Anti-Idiotypic; Aquaporin 4; Autoantibodies; Autoimmunity; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Neuromyelitis Optica | 2017 |
Neuromyelitis optica spectrum disorder presenting in an octogenarian.
Topics: Aged, 80 and over; Aquaporin 4; Azathioprine; Brain Stem; Diagnosis, Differential; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Plasma Exchange; Sjogren's Syndrome; Spinal Cord | 2018 |
[Neuromyelitis optica].
Topics: Antibodies, Monoclonal, Murine-Derived; Aquaporin 4; Astrocytes; Autoantibodies; Azathioprine; Diagnosis, Differential; Humans; Immunologic Factors; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Rituximab | 2013 |
[Diagnosis and treatment of neuromyelitis optica].
Topics: Adult; Algorithms; Aquaporin 4; Azathioprine; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Plasmapheresis; Practice Guidelines as Topic; Steroids | 2014 |
[Topics of neuromyelitis optica].
Topics: Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Aquaporin 4; Autoantibodies; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Japan; Male; Methylprednisolone; Molecular Targeted Therapy; Neuromyelitis Optica; Prednisolone; Pulse Therapy, Drug; Recurrence; Rituximab; Sex Factors | 2014 |
Multiple sclerosis and pregnancy in the 'treatment era'.
Topics: Analgesia, Epidural; Analgesia, Obstetrical; Breast Feeding; Contraindications; Counseling; Female; Humans; Immunoglobulins, Intravenous; Infertility, Female; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Preconception Care; Pregnancy; Pregnancy Complications; Prenatal Care; Reproductive Techniques, Assisted; Risk Factors; Secondary Prevention | 2015 |
Genetic Anticipation in Familial Neuromyelitis Optica: Case and Literature Review.
Topics: Adult; Age of Onset; Aged; Antibodies, Monoclonal, Murine-Derived; Anticipation, Genetic; Aquaporin 4; Female; Humans; Methylprednisolone; Myelitis, Transverse; Neuromyelitis Optica; Retrospective Studies; Rituximab | 2015 |
The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data.
Topics: Autoimmune Diseases; Child; Chorea; Cyclophosphamide; Guillain-Barre Syndrome; Humans; Immunoglobulins, Intravenous; Immunotherapy; Methylprednisolone; Mitoxantrone; Multiple Sclerosis; Natalizumab; Nervous System; Neurodegenerative Diseases; Neuromyelitis Optica; Obsessive-Compulsive Disorder; Plasma Exchange; Rituximab; Streptococcal Infections; Tourette Syndrome | 2015 |
[Demyelinating diseases in children with acute neurological symptoms].
Topics: Child; Child, Preschool; Demyelinating Diseases; Diagnosis, Differential; Encephalomyelitis, Acute Disseminated; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Myelitis, Transverse; Neuromyelitis Optica; Neuroprotective Agents; Optic Neuritis | 2015 |
Primary Sjögren Syndrome in a Child with a Neuromyelitis Optica Spectrum Disorder.
Topics: Child; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Prednisone; Rare Diseases; Risk Assessment; Sjogren's Syndrome; Treatment Outcome | 2016 |
Pediatric Demyelination.
Topics: Child; Child, Preschool; Demyelinating Diseases; Encephalomyelitis, Acute Disseminated; Female; Humans; Male; Methylprednisolone; Multiple Sclerosis; Myelitis, Transverse; Neuromyelitis Optica | 2016 |
Anti-NMDAR encephalitis followed by seropositive neuromyelitis optica spectrum disorder: A case report and literature review.
Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Aquaporin 4; Autoantibodies; Humans; Male; Methylprednisolone; Neuromyelitis Optica; Receptors, N-Methyl-D-Aspartate | 2017 |
[Treatment of NMO].
Topics: Acute-Phase Reaction; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Humans; Immunosuppressive Agents; Interferon beta-1b; Interferon-beta; Methylprednisolone; Mitoxantrone; Neuromyelitis Optica; Plasma Exchange; Prednisolone; Pulse Therapy, Drug; Recurrence; Rituximab | 2009 |
EFNS guidelines on diagnosis and management of neuromyelitis optica.
Topics: Electrodiagnosis; Humans; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Neuroprotective Agents; Plasma Exchange | 2010 |
[Treatment and clinical management of patients with neuromyelitis optica and anti-aquaporin 4 antibody].
Topics: Aquaporin 4; Autoantibodies; Humans; Immunosuppressive Agents; Methylprednisolone; Neuromyelitis Optica; Plasmapheresis | 2010 |
[Case of NMO (neuromyelitis optica) spectum disorder triggered by interferon alpha, which involved extensive pyramidal tract lesion of the brain].
Topics: Aged; Aquaporin 4; Autoantibodies; Biomarkers; Female; Hepatitis C; Humans; Interferon-alpha; Methylprednisolone; Neuromyelitis Optica; Pulse Therapy, Drug; Pyramidal Tracts; Treatment Outcome | 2012 |
[Demyelinating disease].
Topics: Adrenoleukodystrophy; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Autoimmunity; Benzodiazepines; Diffuse Cerebral Sclerosis of Schilder; Encephalomyelitis, Acute Disseminated; Humans; Methylprednisolone; Multiple Sclerosis; Myelin Basic Protein; Myelin Proteolipid Protein; Neuromyelitis Optica; Olanzapine; Pirenzepine; Pulse Therapy, Drug; Selective Serotonin Reuptake Inhibitors; T-Lymphocytes | 2003 |
Post-infectious encephalomyelitis.
Topics: Brain; Central Nervous System Viral Diseases; Diagnosis, Differential; Encephalomyelitis, Acute Disseminated; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Neuroprotective Agents; Spinal Cord | 2005 |
4 trial(s) available for methylprednisolone and Devic Disease
Article | Year |
---|---|
Batoclimab as an add-on therapy in neuromyelitis optica spectrum disorder patients with acute attacks.
Topics: Antibodies, Monoclonal; Aquaporin 4; Autoantibodies; Humans; Immunoglobulin G; Infant, Newborn; Methylprednisolone; Myelitis; Neuromyelitis Optica; Optic Neuritis | 2023 |
A pilot study comparing treatments for severe attacks of neuromyelitis optica spectrum disorders: Intravenous methylprednisolone (IVMP) with add-on plasma exchange (PLEX) versus simultaneous ivmp and PLEX.
Topics: Acute Disease; Adult; Combined Modality Therapy; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Outcome Assessment, Health Care; Pilot Projects; Plasma Exchange; Severity of Illness Index | 2020 |
Persistently Gadolinium-Enhancing Lesion Is a Predictor of Poor Prognosis in NMOSD Attack: a Clinical Trial.
Topics: Adult; Biomarkers; China; Female; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Neuroprotective Agents; Predictive Value of Tests; Prognosis; Prospective Studies | 2021 |
A pilot safety study of ublituximab, a monoclonal antibody against CD20, in acute relapses of neuromyelitis optica spectrum disorder.
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antigens, CD20; Drug Therapy, Combination; Female; Humans; Male; Methylprednisolone; Neuromyelitis Optica; Pilot Projects; Recurrence; Treatment Outcome | 2019 |
129 other study(ies) available for methylprednisolone and Devic Disease
Article | Year |
---|---|
Neuromyelitis optica spectrum disorder with active replication of hepatitis B virus and seropositive anti-aquaporin-4 antibody: A case report.
Topics: Adrenal Cortex Hormones; Adult; Aquaporin 4; Autoantibodies; Diagnosis, Differential; Female; Hepatitis B, Chronic; Humans; Infusions, Intravenous; Methylprednisolone; Neuromyelitis Optica | 2021 |
Early Initiation of Tocilizumab Treatment Against Moderate-to-Severe Myelitis in Neuromyelitis Optica Spectrum Disorder.
Topics: Activities of Daily Living; Adult; Aged; Antibodies, Monoclonal, Humanized; Female; Humans; Male; Methylprednisolone; Middle Aged; Myelitis; Neuromyelitis Optica; Quality of Life; Recurrence | 2021 |
Factors influencing intravenous methylprednisolone pulse therapy in Chinese patients with isolated optic neuritis associated with AQP4 antibody-seropositive neuromyelitis optica.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Aquaporin 4; Autoantibodies; Autoantigens; Child; China; Disease Management; Disease Susceptibility; Female; Humans; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Optic Neuritis; Treatment Outcome; Visual Acuity; Young Adult | 2021 |
Long-Term Visual Prognosis in Patients With Aquaporin-4-Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder.
Topics: Aquaporin 4; Autoantibodies; Female; Humans; Immunoglobulin G; Male; Methylprednisolone; Neuromyelitis Optica; Optic Neuritis; Prognosis; Tomography, Optical Coherence | 2022 |
Spectrum of pediatric acquired demyelinating syndromes (PADS) of the central nervous system in a tropical developing country: A 10-year retrospective study.
Topics: Child; Cross-Sectional Studies; Developing Countries; Female; Humans; Male; Methylprednisolone; Neuromyelitis Optica; Prednisone; Retrospective Studies; Syndrome; White Matter | 2022 |
Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) is a promising predictor for the severity of acute AQP4-IgG positive neuromyelitis optica spectrum disorder.
Topics: Aquaporin 4; Autoantibodies; Humans; Immunoglobulin G; Methylprednisolone; Neuromyelitis Optica | 2023 |
Systemic lupus erythematosus with acute ischemic optic neuropathy complicated with neuromyelitis optica: a case report.
Topics: Adult; Autoantibodies; Autoimmune Diseases; Female; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Neuromyelitis Optica; Optic Neuropathy, Ischemic; Young Adult | 2023 |
Chiasmitis Secondary to Neuromyelitis Optica 25 Years After Initial Optic Neuritis.
Topics: Aquaporin 4; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Optic Chiasm; Optic Neuritis; Vision Disorders; Visual Acuity | 2019 |
Retrospective study of the adverse events of the treatment for an acute attack of neuromyelitis optica spectrum disorder.
Topics: Acute Disease; Administration, Intravenous; Adult; Female; Glucocorticoids; Humans; Hyperglycemia; Hypocalcemia; Hypotension; Infections; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Plasma Exchange; Retrospective Studies; Thailand | 2020 |
Neuromyelitis optica spectrum disorder and systemic lupus erythematosus.
Topics: Adolescent; Aquaporin 4; Autoantibodies; Female; Humans; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Plasma Exchange; Spinal Cord | 2019 |
Neuromyelitis optica spectrum disorder with severe orthostatic hypotension due to hypothalamic lesions.
Topics: Adolescent; Disorders of Excessive Somnolence; Female; Glucocorticoids; Humans; Hypotension, Orthostatic; Hypothalamus; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica | 2020 |
Clinical features of transverse myelitis associated with systemic lupus erythematosus.
Topics: Adult; Antibodies, Anticardiolipin; Aquaporin 4; C-Reactive Protein; Case-Control Studies; China; Comorbidity; Female; Glucocorticoids; Humans; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Middle Aged; Myelitis, Transverse; Neuromyelitis Optica; Prognosis; Retrospective Studies | 2020 |
Isolated opsoclonus heralding neuromyelitis optica spectrum disorder.
Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Immunologic Factors; Methylprednisolone; Neuromyelitis Optica; Ocular Motility Disorders; Rituximab | 2020 |
Acute bilateral cerebral infarction in the presence of neuromyelitis optica spectrum disorder: A case report.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Anticholesteremic Agents; Aphasia, Broca; Aspirin; Atorvastatin; Benzofurans; Cerebral Infarction; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Neuroprotective Agents; Plasmapheresis; Platelet Aggregation Inhibitors; Treatment Outcome | 2020 |
Area postrema syndrome: a neurological presentation of nausea, vomiting and hiccups.
Topics: Adult; Anti-Inflammatory Agents; Aquaporin 4; Area Postrema; Asian People; Drug Therapy, Combination; Evoked Potentials, Visual; Female; Hiccup; Humans; Immunoglobulin G; Immunologic Factors; Magnetic Resonance Imaging; Methylprednisolone; Nausea; Neuromyelitis Optica; Rituximab; Treatment Outcome; Vomiting | 2020 |
Intravenous immunoglobulin as the rescue treatment in NMOSD patients.
Topics: Aquaporin 4; Autoantibodies; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Neuromyelitis Optica; Recurrence; Retrospective Studies | 2021 |
Rescue immunoadsorption treatment for neuromyelitis optica spectrum disorder attacks unresponsive to intravenous methylprednisolone.
Topics: Administration, Intravenous; Adult; Anti-Inflammatory Agents; China; Databases, Factual; Female; Humans; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Plasmapheresis; Treatment Outcome; Young Adult | 2021 |
Clinical characteristics of intractable or persistent hiccups and nausea associated with herpes zoster.
Topics: Acyclovir; Adult; Aged; Aged, 80 and over; Antiemetics; Antiviral Agents; Cranial Nerve Diseases; Diagnosis, Differential; Female; Herpes Zoster; Hiccup; Humans; Male; Methylprednisolone; Middle Aged; Nausea; Neuromyelitis Optica; Retrospective Studies | 2021 |
Oral administration of methylprednisolone powder for intravenous injection dissolved in water to treat MS and NMOSD relapses during COVID-19 pandemic in a real-world setting.
Topics: Administration, Oral; COVID-19; Humans; Injections, Intravenous; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Pandemics; Powders; Recurrence; Retrospective Studies; SARS-CoV-2; Water | 2021 |
Neuromyelitis optica and concomitant pulmonary tuberculosis: a case report.
Topics: Aquaporin 4; Autoantibodies; Humans; Male; Methylprednisolone; Neuromyelitis Optica; Tuberculosis, Pulmonary | 2021 |
Psychiatric symptoms as initial manifestation in neuromyelitis optica spectrum disorder without cortical lesions: A report of two cases.
Topics: Adult; Cerebral Cortex; Diagnosis, Differential; Female; Glucocorticoids; Humans; Male; Mental Disorders; Methylprednisolone; Middle Aged; Neuromyelitis Optica | 2021 |
CD8-Positive T-Cell Leukoencephalitis With Astrocytopathy Clinically Presenting as Neuromyelitis Optica.
Topics: Anti-Inflammatory Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Astrocytes; Autopsy; CD8-Positive T-Lymphocytes; Demyelinating Diseases; Encephalitis; Fatal Outcome; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Spinal Cord; White Matter | 2017 |
Treatment-resistant neuromyelitis optica spectrum disorders associated with Toxocara canis infection: A case report.
Topics: Albendazole; Antibodies; Antiprotozoal Agents; Aquaporin 4; Drug Resistance; Female; Humans; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Toxocariasis | 2017 |
Hiccups as Herald: Neuromyelitis Optica Spectrum Disorder.
Topics: Adrenal Cortex Hormones; Biomarkers; Diagnosis, Differential; Drug Therapy, Combination; Hiccup; Humans; Immunologic Factors; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Rituximab; Spinal Puncture | 2017 |
Intractable Nausea Due to the Area Postrema Syndrome of Neuromyelitis Optica: An Uncommon Cause of a Common Symptom.
Topics: Adult; Antiemetics; Antirheumatic Agents; Area Postrema; Emergency Service, Hospital; Female; Headache; Humans; Magnetic Resonance Imaging; Methylprednisolone; Nausea; Neuromyelitis Optica; Paresis; Rituximab; Thiamine; Tomography, X-Ray Computed; Vitamin B Complex | 2017 |
Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aquaporin 4; Autoantibodies; Combined Modality Therapy; Early Medical Intervention; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Myelin-Oligodendrocyte Glycoprotein; Neuromyelitis Optica; Optic Neuritis; Plasma Exchange; Retrospective Studies; Severity of Illness Index; Time-to-Treatment; Treatment Outcome; Young Adult | 2018 |
Serum anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder presenting as acute eosinophilic encephalomyelitis.
Topics: Anti-Inflammatory Agents; Antibodies, Anti-Idiotypic; Aquaporin 4; Encephalomyelitis; Eosinophils; Humans; Immunoglobulin E; Leukocyte Count; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica | 2018 |
Clinical commentary on "Two cases of anaphylactic shock by methylprednisolone in neuromyelitis optica".
Topics: Anaphylaxis; Aquaporin 4; Humans; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica | 2018 |
Two cases of anaphylactic shock by methylprednisolone in neuromyelitis optica.
Topics: Adult; Anaphylaxis; Anti-Inflammatory Agents; Comorbidity; Female; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Neuromyelitis Optica | 2018 |
A woman with intractable nausea and vomiting.
Topics: Adult; Alkalosis; Antiemetics; Azathioprine; Delayed Diagnosis; Female; Functional Neuroimaging; Humans; Immunologic Factors; Magnetic Resonance Imaging; Medulla Oblongata; Methylprednisolone; Nausea; Neuromyelitis Optica; Plasma Exchange; Rituximab; Treatment Outcome; Vomiting; Weight Loss | 2018 |
Intractable nausea and vomiting as an uncommon presentation in an anti-aquaporin 4-positive patient.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aquaporin 4; Autoantibodies; Female; Glucocorticoids; Humans; Methylprednisolone; Myelitis, Transverse; Nausea; Neuromyelitis Optica; Prednisolone; Vomiting | 2018 |
[A case of neuromyelitis optica spectrum disorders complicated with systemic lupus erythematosus and thymoma].
Topics: Anti-Inflammatory Agents; Antibodies; Aquaporin 4; Humans; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Thymoma; Treatment Outcome | 2018 |
Low vitamin D-25(OH) level in Indonesian multiple sclerosis and neuromyelitis optic patients.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Cross-Sectional Studies; Disability Evaluation; Female; Humans; Indonesia; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neuromyelitis Optica; Statistics, Nonparametric; Vitamin D; Vitamin D Deficiency; Young Adult | 2018 |
Radiomics Analysis of DTI Data to Assess Vision Outcome After Intravenous Methylprednisolone Therapy in Neuromyelitis Optic Neuritis.
Topics: Adult; Diffusion Tensor Imaging; Female; Glucocorticoids; Humans; Imaging, Three-Dimensional; Male; Methylprednisolone; Neuromyelitis Optica; Plasma Exchange; Retrospective Studies; Sensitivity and Specificity; Visual Acuity | 2019 |
Neuromyelitis optica with unilateral diaphragmatic paralysis.
Topics: Adult; Autoantibodies; Biomarkers; Disease Progression; Female; Humans; Methylprednisolone; Neuromyelitis Optica; Paresis; Plasmapheresis; Respiratory Paralysis; Secondary Prevention | 2018 |
[Elderly onset case of neuromyelitis optica that developed at the age of 90].
Topics: Age Factors; Aged, 80 and over; Aquaporin 4; Autoantibodies; Cervical Vertebrae; Extremities; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Muscle Weakness; Myelitis; Neuroimaging; Neuromyelitis Optica; Optic Nerve; Pulse Therapy, Drug; Recurrence; Spinal Cord; Time Factors; Treatment Outcome | 2018 |
A multi-facet comparative analysis of neuromyelitis optica spectrum disorders in patients with seropositive and seronegative AQP4-IgG.
Topics: Adult; Aquaporin 4; Autoantibodies; Comorbidity; Disability Evaluation; Female; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Neuroprotective Agents; Retrospective Studies; Sex Factors; Young Adult | 2018 |
Hypersomnia as an isolated symptom of neuromyelitis optica.
Topics: Antibiotics, Antineoplastic; Aquaporin 4; Autoantibodies; Disorders of Excessive Somnolence; Electroencephalography; Female; Glucocorticoids; Humans; Hypothalamus; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Mycophenolic Acid; Neuromyelitis Optica; Treatment Outcome | 2018 |
Unusual Cause of Intractable Vomiting in a Young Girl.
Topics: Anti-Inflammatory Agents; Child, Preschool; Female; Humans; Methylprednisolone; Neuromyelitis Optica; Vomiting | 2019 |
Glucocorticoid induced acute paraplegia in a patient with intracranial dural arteriovenous fistula.
Topics: Central Nervous System Vascular Malformations; Diagnostic Errors; Female; Glucocorticoids; Humans; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Paraplegia | 2019 |
Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder.
Topics: Adult; Aquaporin 4; Autoantibodies; Combined Modality Therapy; Cyclophosphamide; Disability Evaluation; Drug Evaluation; Female; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Myelitis; Neuromyelitis Optica; Plasmapheresis; Retrospective Studies; Severity of Illness Index; Syndrome; Treatment Outcome; Young Adult | 2013 |
Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Aquaporin 4; Brain; Brain Injuries; C-Reactive Protein; Chi-Square Distribution; Complement System Proteins; Diffusion Tensor Imaging; Disability Evaluation; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Neuromyelitis Optica; Oligoclonal Bands; Retrospective Studies | 2013 |
Successful treatment for neuromyelitis optica with systemic lupus erythematosus.
Topics: Adult; Female; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Mycophenolic Acid; Neuromyelitis Optica; Prednisone; Young Adult | 2013 |
The onset location of neuromyelitis optica spectrum disorder predicts the location of subsequent relapses.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Brain; Brain Stem; Child; Female; Humans; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Optic Nerve; Plasmapheresis; Recovery of Function; Recurrence; Retrospective Studies; Spinal Cord; Young Adult | 2014 |
Bilateral hearing loss as a manifestation of neuromyelitis optica.
Topics: Female; Hearing Loss, Bilateral; Hearing Tests; Humans; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Neuroprotective Agents; Plasmapheresis; Treatment Outcome | 2014 |
[Case of neuromyelitis optica spectrum disorder associated with central pontine and extrapontine myelinolysis preceded by syndrome of inappropriate antidiuretic hormone secretion].
Topics: Adult; Aquaporin 4; Biomarkers; Brain; Humans; Inappropriate ADH Syndrome; Magnetic Resonance Imaging; Male; Methylprednisolone; Myelinolysis, Central Pontine; Neuromyelitis Optica; Plasma Exchange; Prednisolone; Pulse Therapy, Drug; Sodium; Treatment Outcome | 2014 |
Sudden onset of sleep due to hypothalamic lesions in neuromyelitis optica spectrum disorder positive for anti-aquaporin-4 antibody.
Topics: Adult; Aquaporin 4; Autoantibodies; Biomarkers; Disorders of Excessive Somnolence; Female; Glucocorticoids; Humans; Hypothalamus; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Pulse Therapy, Drug; Sleep; Treatment Outcome | 2014 |
Pregnancy outcomes in a woman with neuromyelitis optica.
Topics: Adult; Aquaporin 4; Female; Humans; Immunoglobulin G; Methylprednisolone; Neuromyelitis Optica; Plasma Exchange; Pregnancy; Pregnancy Complications | 2014 |
Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody.
Topics: Adult; Antibodies, Blocking; Astrocytes; Demyelinating Diseases; Glial Fibrillary Acidic Protein; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Myelin-Oligodendrocyte Glycoprotein; Myelitis, Transverse; Neuromyelitis Optica; Neuroprotective Agents | 2015 |
Association of circulating follicular helper T cells with disease course of NMO spectrum disorders.
Topics: Adult; Aged; Anti-Inflammatory Agents; Case-Control Studies; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunoglobulin G; Leukocytes, Mononuclear; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neuromyelitis Optica; Severity of Illness Index; T-Lymphocytes, Helper-Inducer; Young Adult | 2015 |
[Successful treatment of neuromyelitis optica spectrum disorder by early initiation of plasma exchange].
Topics: Adult; Aquaporin 4; Autoantibodies; Biomarkers; Deglutition Disorders; Drug Resistance; Dysarthria; Female; Glucocorticoids; Hiccup; Humans; Hypoglossal Nerve Diseases; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Plasma Exchange; Pulse Therapy, Drug; Time Factors; Treatment Outcome; Vomiting | 2015 |
Medical image. Neuromyelitis optica masquerading as sepsis.
Topics: Diagnosis, Differential; Female; Glucocorticoids; Humans; Immunocompromised Host; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Sepsis; Young Adult | 2015 |
The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antigens, CD; Aquaporin 4; B-Lymphocyte Subsets; Cytokines; Female; Flow Cytometry; Humans; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Rituximab; Time Factors; Young Adult | 2015 |
Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
Topics: Acute Disease; Administration, Intravenous; Adult; Cohort Studies; Combined Modality Therapy; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Plasma Exchange; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Severe aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder with short myelitis lesion and favourable outcome.
Topics: Anti-Inflammatory Agents; Aquaporin 4; Female; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Methylprednisolone; Myelitis; Neuromyelitis Optica; Treatment Outcome; Young Adult | 2015 |
[Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
Topics: Adolescent; Anti-Inflammatory Agents; Aquaporin 4; Autoantibodies; Brain; Brain Diseases; Child; Child, Preschool; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Infant; Magnetic Resonance Imaging; Male; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Retrospective Studies | 2015 |
Neuromyelitis optica and myasthenia gravis in a young Nigerian girl.
Topics: Adolescent; Anti-Inflammatory Agents; Autoantibodies; Cholinesterase Inhibitors; Female; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Methylprednisolone; Myasthenia Gravis; Neuromyelitis Optica; Nigeria; Paraparesis, Spastic; Pyridostigmine Bromide; Spinal Cord; Treatment Outcome | 2015 |
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder Patients in Turkish Cohort: Demographic, Clinical, and Laboratory Features.
Topics: Adolescent; Adult; Age of Onset; Aged; Anti-Inflammatory Agents; Aquaporin 4; Cohort Studies; Demography; Disability Evaluation; Disease Progression; Female; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Turkey; Young Adult | 2015 |
Neuromyelitis Optica (NMO) with Abdominal Tuberculosis (TB).
Topics: Antitubercular Agents; Evoked Potentials, Visual; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Mycobacterium tuberculosis; Neuromyelitis Optica; Paraplegia; Spinal Cord; Treatment Outcome; Tuberculosis; Young Adult | 2015 |
Efficacy of intravenous methylprednisolone pulse therapy in patients with multiple sclerosis and neuromyelitis optica.
Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neuromyelitis Optica; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Neuromyelitis Optica Spectrum Disorder Associated with Cervical Spondylosis.
Topics: Adult; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Spondylosis | 2015 |
Innocent Until Proven Guilty.
Topics: Adult; Cerebral Angiography; Cyclophosphamide; Diagnosis, Differential; Fatal Outcome; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Multimodal Imaging; Neuromyelitis Optica | 2016 |
Plasma Exchange and Immunoadsorption in Pediatric Inflammatory Optic Neuropathy Resistant to Corticosteroid Therapy: Four French Cases.
Topics: Adolescent; Child; Female; France; Glucocorticoids; Humans; Immunosorbent Techniques; Male; Meningitis; Methylprednisolone; Neuromyelitis Optica; Optic Neuritis; Phenylketonurias; Plasma Exchange; Recurrence | 2016 |
Myelin Oligodendrocyte Glycoprotein-Associated Pediatric Central Nervous System Demyelination: Clinical Course, Neuroimaging Findings, and Response to Therapy.
Topics: Autoantibodies; Brain; Child; Child, Preschool; Demyelinating Diseases; Encephalomyelitis, Acute Disseminated; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Magnetic Resonance Imaging; Male; Methylprednisolone; Myelin-Oligodendrocyte Glycoprotein; Myelitis, Transverse; Neuromyelitis Optica; Retrospective Studies; Spinal Cord; Treatment Outcome | 2016 |
Neuromyelitis optica accompanied by nephrotic syndrome and autoimmune-related pancytopenia.
Topics: Adult; Anti-Inflammatory Agents; Brain; Diagnosis, Differential; Fatal Outcome; Female; Humans; Methylprednisolone; Nephrotic Syndrome; Neuromyelitis Optica; Pancytopenia; Skin | 2016 |
Effects of early using azathioprine in the acute phase in neuromyelitis optica spectrum disorder.
Topics: Acute Disease; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Retrospective Studies; Statistics, Nonparametric; Survival Analysis; Young Adult | 2017 |
[Anti-MOG + neuromyelitis optica spectrum disorders treated with plasmapheresis].
Topics: Autoantibodies; Azathioprine; Child; Humans; Male; Methylprednisolone; Myelin-Oligodendrocyte Glycoprotein; Neuromyelitis Optica; Plasmapheresis; Prednisolone; Pulse Therapy, Drug; Treatment Outcome | 2016 |
Catastrophic presentation of a patient with combined NMOSD and thrombotic thrombocytopenic purpura/hemolytic uremic syndrome: a case report.
Topics: Adult; Anti-Inflammatory Agents; Female; Hemolytic-Uremic Syndrome; Humans; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Purpura, Thrombotic Thrombocytopenic; Spinal Cord | 2017 |
Clinical analysis of neuromyelitis optica presenting as intractable nausea, vomiting and hiccups.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Cervical Cord; Female; Hiccup; Humans; Magnetic Resonance Imaging; Medulla Oblongata; Methylprednisolone; Middle Aged; Nausea; Neuromyelitis Optica; Treatment Outcome; Vomiting; Young Adult | 2017 |
A case of anti aquapolin-4 antibody positive myelitis with hyperhidrosis, following herpes zoster.
Topics: Acyclovir; Aquaporin 4; Autoantibodies; Female; Herpes Zoster; Herpesvirus 3, Human; Humans; Hyperhidrosis; Immunoglobulin G; Infusions, Intravenous; Methylprednisolone; Middle Aged; Myelitis; Neuromyelitis Optica; Recurrence; Thoracic Vertebrae; Time Factors; Treatment Outcome | 2017 |
[Neuromyelitis optica presenting concomitantly with systemic lupus erythematosus: Report of one case].
Topics: Adult; Antirheumatic Agents; Cyclophosphamide; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Neuromyelitis Optica; Paresis; Rituximab; Spasm | 2016 |
Etiologic spectrum and functional outcome of the acute inflammatory myelitis.
Topics: Adult; Anti-Inflammatory Agents; Encephalomyelitis; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelitis, Transverse; Neuromyelitis Optica; Recovery of Function; Retrospective Studies; Treatment Outcome; Young Adult | 2017 |
A case of neuromyelitis optica spectrum disorder (NMOSD) with Sjögren's syndrome manifested only brain involvement by preceding parotitis.
Topics: Adult; Autoantibodies; Biomarkers; Brain; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Parotitis; Plasma Exchange; Pulse Therapy, Drug; Recurrence; Sjogren's Syndrome; Tacrolimus; Treatment Outcome | 2017 |
CNS aquaporin-4 autoimmunity in children.
Topics: Adolescent; Aquaporin 4; Autoantibodies; Autoimmunity; Biomarkers; Brain; Child; Child, Preschool; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Myelitis, Transverse; Neuromyelitis Optica; Recurrence; Serologic Tests | 2008 |
A prominent elevation of glial fibrillary acidic protein in the cerebrospinal fluid during relapse in neuromyelitis optica.
Topics: Adult; Aquaporin 4; Biomarkers; Female; Glial Fibrillary Acidic Protein; Humans; Injections, Intravenous; Methylprednisolone; Neuromyelitis Optica; Recurrence; Vision Disorders | 2008 |
Spectrum of pediatric neuromyelitis optica.
Topics: Adolescent; Antibodies, Antiphospholipid; Atrophy; Brain; Child; Child, Preschool; Female; Glucocorticoids; Humans; Immunoglobulin G; Infant; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Recurrence; Sensitivity and Specificity; Spinal Cord | 2008 |
Childhood optic neuritis: the pediatric neurologist's perspective.
Topics: Adolescent; Age Factors; Chickenpox; Child; Child, Preschool; Female; Follow-Up Studies; Functional Laterality; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Mumps; Neuromyelitis Optica; Optic Neuritis; Recovery of Function; Recurrence; Rubella; Sex Factors | 2009 |
Neuromyelitis optica with CSF examination mimicking bacterial meningomyelitis.
Topics: Anti-Inflammatory Agents; Blindness; Diagnosis, Differential; Female; Humans; Leukocytosis; Magnetic Resonance Imaging; Male; Meningitis, Bacterial; Methylprednisolone; Middle Aged; Myelitis, Transverse; Neck Pain; Neuromyelitis Optica; Optic Nerve; Paraplegia; Recurrence; Spinal Cord; Vision, Low | 2009 |
[Neuromyelitis optica with atypical cerebral lesions demonstrated by magnetic resonance imaging in a 9-year old girl].
Topics: Brain; Child; Diagnosis, Differential; Female; Humans; Immunoglobulin G; Immunologic Factors; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Spinal Cord | 2009 |
Linear medullary pericanal lesion with longitudinal myelitis can be diagnostic of neuromyelitis optica.
Topics: Anti-Inflammatory Agents; Cervical Vertebrae; Female; Humans; Magnetic Resonance Imaging; Medulla Oblongata; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Sjogren's Syndrome; Thoracic Vertebrae | 2009 |
Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders.
Topics: Adolescent; Adult; Antibodies; Aquaporin 4; Autoimmunity; Body Water; Brain; Brain Edema; Cerebrovascular Disorders; Child; Comorbidity; Confusion; Consciousness Disorders; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Female; Gadolinium; Humans; Immunoglobulins, Intravenous; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Remission, Spontaneous; Syndrome; Time Factors; Young Adult | 2009 |
Narcolepsy as an initial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody.
Topics: Adult; Aquaporin 4; Autoantibodies; Biomarkers; Disease Progression; Female; Humans; Hypothalamus; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Magnetic Resonance Imaging; Mesencephalon; Methylprednisolone; Narcolepsy; Neuromyelitis Optica; Neuropeptides; Ocular Motility Disorders; Orexins; Polysomnography; Predictive Value of Tests; Recurrence; Spinal Cord; Treatment Outcome | 2009 |
A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset.
Topics: Adult; Age of Onset; Aquaporin 4; Astrocytes; Autoantibodies; Biomarkers; Blood-Brain Barrier; Disease Progression; Female; Humans; Japan; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Paraparesis; Plasmapheresis; Spinal Cord; Time Factors; Treatment Outcome | 2009 |
A possible paraneoplastic neuromyelitis optica associated with lung cancer.
Topics: Anti-Inflammatory Agents; Antibodies; Aquaporin 4; Carcinoma, Non-Small-Cell Lung; Disease Progression; Evoked Potentials, Visual; Female; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Neuromyelitis Optica | 2009 |
Patient with neuromyelitis optica and inflammatory demyelinating lesions comprising whole spinal cord from C2 level till conus: case report.
Topics: Adult; Cyclophosphamide; Diagnosis, Differential; Disease Progression; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Spinal Cord; Treatment Outcome | 2009 |
The borderland of neuromyelitis optica.
Topics: Adult; Antibodies, Antinuclear; Aquaporin 4; Female; History, 19th Century; History, 20th Century; Humans; Methylprednisolone; Neuromyelitis Optica; Neuroprotective Agents | 2009 |
Neurological pictures. Primary Sjögren syndrome presenting as neuromyelitis optica.
Topics: Anti-Inflammatory Agents; Antibodies, Antinuclear; Diagnosis, Differential; Female; Humans; Leukocyte Count; Lymphocytes; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Optic Chiasm; Salivary Glands; Sjogren's Syndrome; Spinal Cord; Young Adult | 2010 |
Hiccups, nausea, and vomiting: water channels under attack!
Topics: Adolescent; Female; Hiccup; Humans; Infusions, Intravenous; Methylprednisolone; Nausea; Neuromyelitis Optica; Vomiting | 2010 |
[Neuromyelitis optica in a patient with Sjögren syndrome with distal renal tubular acidosis: case report].
Topics: Acidosis, Renal Tubular; Adult; Aquaporin 4; Autoantibodies; Biomarkers; Female; Humans; Methylprednisolone; Neuromyelitis Optica; Plasmapheresis; Prednisolone; Pulse Therapy, Drug; Sjogren's Syndrome; Treatment Outcome | 2010 |
Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica.
Topics: Adult; Female; Glucocorticoids; Humans; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Nerve Fibers; Neuromyelitis Optica; Optic Disk; Retinal Ganglion Cells; Tomography, Optical Coherence; Visual Acuity | 2010 |
Breast lymphoma in Sjögren's syndrome complicated by acute monocular blindness.
Topics: Aged; Blindness; Breast Neoplasms; Combined Modality Therapy; Diagnosis, Differential; Female; Humans; Lymphoma; Mastectomy, Radical; Methylprednisolone; Neoplasm Metastasis; Neuromyelitis Optica; Prednisone; Radiography, Thoracic; Sjogren's Syndrome; Teaching Rounds | 2010 |
Neuromyelitis optica associated with subacute human T-lymphotropic virus type 1 infection.
Topics: Deltaretrovirus Infections; Human T-lymphotropic virus 1; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Optic Nerve; Paraparesis, Tropical Spastic; Spinal Cord | 2010 |
Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study.
Topics: Adult; Aged; Antibodies; Aquaporin 4; Astrocytes; Biomarkers; Central Nervous System; Demyelinating Diseases; Disability Evaluation; Encephalomyelitis, Acute Disseminated; Female; Follow-Up Studies; Glial Fibrillary Acidic Protein; Humans; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Nerve Growth Factors; Nervous System Diseases; Neurofilament Proteins; Neuromyelitis Optica; Neuroprotective Agents; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Statistics, Nonparametric | 2010 |
A case of cerebral aquaporinopathy.
Topics: Adult; Anti-Inflammatory Agents; Antibodies; Antibodies, Antineutrophil Cytoplasmic; Aquaporin 4; Area Postrema; Brain; Female; Hiccup; Humans; Magnetic Resonance Imaging; Medulla Oblongata; Methylprednisolone; Myelitis, Transverse; Myeloblastin; Neurologic Examination; Neuromyelitis Optica; Peroxidase; Recurrence; Spinal Cord | 2010 |
A case of neuromyelitis optica developing into myelitis 25 years after optic neuritis.
Topics: Adolescent; Aquaporin 4; Autoantibodies; Cerebrospinal Fluid Pressure; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Methylprednisolone; Myelitis; Neuromyelitis Optica; Optic Neuritis | 2010 |
A case of chronic progressive myelopathy.
Topics: Anti-Inflammatory Agents; Aquaporin 4; Autoantibodies; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Muscle Strength; Neurologic Examination; Neuromyelitis Optica; Plasmapheresis; Spinal Cord | 2010 |
Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis.
Topics: Anti-Inflammatory Agents; Aquaporin 4; Autoantibodies; Brain; Facial Nerve Diseases; Female; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Muscle Weakness; Myelitis, Transverse; Neuromyelitis Optica; Prednisolone; Scleroderma, Systemic; Spinal Cord | 2011 |
[Recurrent acute rhombencephalomyelitis in an adult or neuromyelitis optica? Presentation of a case].
Topics: Azathioprine; Brain Stem; Corticosterone; Encephalitis; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Plasmapheresis; Recurrence; Spinal Cord; Young Adult | 2012 |
Neuromyelitis optica with very late onset.
Topics: Age of Onset; Aged; Anti-Inflammatory Agents; Autoantibodies; Cyclophosphamide; Drug Therapy, Combination; Evoked Potentials, Visual; Female; Follow-Up Studies; Humans; Immunoglobulin G; Immunosuppressive Agents; Infusions, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Neurologic Examination; Neuromyelitis Optica; Prednisone; Spinal Cord; Thoracic Vertebrae | 2011 |
Influenza-associated monophasic neuromyelitis optica.
Topics: Adolescent; Anti-Inflammatory Agents; Antiviral Agents; Aquaporin 4; Autoantibodies; Female; Humans; Influenza A virus; Influenza, Human; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Prednisolone; Zanamivir | 2011 |
[Successful plasma exchange treatment for a case with neuromyelitis optica].
Topics: Adolescent; Aquaporin 4; Autoantibodies; Biomarkers; Combined Modality Therapy; Female; Humans; Methylprednisolone; Neuromyelitis Optica; Plasma Exchange; Pulse Therapy, Drug; Treatment Outcome | 2011 |
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies; Aquaporin 4; Brain Stem; Cohort Studies; Disability Evaluation; Female; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Oligoclonal Bands; Recurrence; Retrospective Studies; Statistics as Topic; Treatment Outcome; Young Adult | 2012 |
Subacute encephalopathy associated with aquaporin-4 autoantibodies: a report of 2 adult cases.
Topics: Adult; Anti-Inflammatory Agents; Aquaporin 4; Autoantibodies; Brain; Cognition Disorders; Female; Fluorescent Antibody Technique, Indirect; Humans; Immunization, Passive; Immunoglobulin G; Immunoglobulins, Intravenous; Leigh Disease; Magnetic Resonance Imaging; Male; Methylprednisolone; Nervous System Diseases; Neuromyelitis Optica; Neuropsychological Tests; Psychotic Disorders; Vision Disorders | 2012 |
NMO spectrum presenting as partial myelitis.
Topics: Adult; Anti-Inflammatory Agents; Brain; Female; Humans; Hyperalgesia; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Muscle Weakness; Myelitis, Transverse; Neuromyelitis Optica; Spinal Cord | 2013 |
Acute reversible periependymal ventricular enhancement in neuromyelitis optica.
Topics: Adult; Brain; Cerebral Ventricles; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Spinal Cord | 2012 |
Neuromyelitis optica in a patient with pemphigus foliaceus.
Topics: Adolescent; Brain; Female; Humans; Immunosuppressive Agents; Methylprednisolone; Mycophenolic Acid; Neuromyelitis Optica; Optic Nerve; Pemphigus; Spinal Cord; Treatment Outcome | 2012 |
Neuromyelitis optica following human papillomavirus vaccination.
Topics: Adolescent; Adverse Drug Reaction Reporting Systems; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Databases, Factual; Female; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Medulla Oblongata; Methylprednisolone; Muscle Weakness; Myelitis, Transverse; Neuromyelitis Optica; Papillomavirus Vaccines; Paraparesis, Spastic; Plasma Exchange; Rituximab; Spinal Cord; Vaccination; Vision Disorders | 2012 |
Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica.
Topics: Acute Disease; Adolescent; Adult; Combined Modality Therapy; Female; Glucocorticoids; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Optic Neuritis; Plasma Exchange; Pulse Therapy, Drug; Retinal Ganglion Cells; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Visual Field Tests; Visual Fields; Young Adult | 2012 |
Lack of response to pulse cyclophosphamide in neuromyelitis optica: evaluation of 7 patients.
Topics: Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Disability Evaluation; Follow-Up Studies; Humans; Immunosuppressive Agents; Methylprednisolone; Neuromyelitis Optica; Retrospective Studies | 2012 |
A rare case of mixed connective tissue disease complicated with neuromyelitis optica.
Topics: Adult; Aquaporin 4; Autoantibodies; Brain; Combined Modality Therapy; Female; Glucocorticoids; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Methylprednisolone; Mixed Connective Tissue Disease; Neuromyelitis Optica; Plasmapheresis; Prednisone; Spine | 2012 |
Pulmonary tuberculosis with neuromyelitis optica: an uncommon association of a common disease.
Topics: Adult; Anti-Inflammatory Agents; Antitubercular Agents; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Mycobacterium tuberculosis; Neuromyelitis Optica; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 2012 |
Spectrum disorder of neuromyelitis optica in a patient presenting with intractable vomiting and hiccups, transverse myelitis and acute encephalopathy.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Brain; Brain Diseases; Female; Hiccup; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Methylprednisolone; Myelitis, Transverse; Neuromyelitis Optica; Plasmapheresis; Rituximab; Spinal Cord; Vomiting | 2012 |
Acute combined central and peripheral demyelination showing anti-aquaporin 4 antibody positivity.
Topics: Acute Disease; Antibodies, Anti-Idiotypic; Aquaporin 4; Carbamazepine; Comorbidity; Female; Humans; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Peripheral Nervous System Diseases; Prednisolone; Treatment Outcome | 2012 |
Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Asian People; Disability Evaluation; Female; Hong Kong; Humans; Immunoglobulins, Intravenous; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Recurrence; Rituximab; Young Adult | 2013 |
Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study.
Topics: Adult; Anti-Inflammatory Agents; Antineoplastic Agents; Cohort Studies; Disability Evaluation; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Neuromyelitis Optica; Prospective Studies; Radiography; Recurrence; Spinal Cord; Treatment Outcome | 2013 |
Devic syndrome: can antiphospholipid antibodies be a factor?
Topics: Adult; Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Anticoagulants; Antirheumatic Agents; Aspirin; Atorvastatin; Azathioprine; Complement C4; Cyclophosphamide; Female; Glucocorticoids; Heparin; Heptanoic Acids; Humans; Hydroxychloroquine; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin G; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Plasmapheresis; Prednisolone; Pulse Therapy, Drug; Pyrroles; Warfarin | 2012 |
[Neuromyelitis optica].
Topics: Humans; Methylprednisolone; Neuromyelitis Optica; Plasmapheresis; Pulse Therapy, Drug; Secondary Prevention | 2012 |
[Neuromyelitis optica (Devic's disease): a severe variant of multiple sclerosis].
Topics: Adult; Diagnosis, Differential; Fatal Outcome; Female; Humans; Methylprednisolone; Multiple Sclerosis; Neuromyelitis Optica; Neuroprotective Agents | 2004 |
[Plasma exchange therapy for steroid-unresponsive multiple sclerosis relapses: clinical experience with 16 patients].
Topics: Activities of Daily Living; Adolescent; Adult; Anti-Inflammatory Agents; Brain; Child; Combined Modality Therapy; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Multiple Sclerosis; Neurologic Examination; Neuromyelitis Optica; Plasma Exchange; Recurrence; Retrospective Studies | 2006 |
Fulminant Devic disease successfully treated by lymphocytapheresis.
Topics: Adult; Anti-Inflammatory Agents; Cytokines; Drug Resistance; Female; Humans; Immunoglobulins, Intravenous; Leukapheresis; Methylprednisolone; Neuromyelitis Optica | 2006 |
Neuromyelitis optica immunoglobulin G in a child.
Topics: Anti-Inflammatory Agents; Autoantibodies; Biomarkers; Child; Female; Humans; Immunoglobulin G; Methylprednisolone; Neuromyelitis Optica | 2006 |
Post-dengue neuromyelitis optica: case report of a Japanese-descendent Brazilian child.
Topics: Anti-Inflammatory Agents; Child; Dengue; Female; Humans; Japan; Methylprednisolone; Neuromyelitis Optica; Optic Nerve; Prednisone | 2006 |
Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica.
Topics: Adult; Anti-Inflammatory Agents; Autoantibodies; Blood-Brain Barrier; Combined Modality Therapy; Drug Resistance; Female; Humans; Immunoglobulin G; Injections, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Plasma Exchange; Recurrence; Spinal Cord | 2007 |
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.
Topics: Adult; Aquaporin 4; Autoantibodies; Biomarkers; Brain; Chi-Square Distribution; Female; Fluorescent Antibody Technique, Indirect; Humans; Immunoglobulin G; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Recurrence; Risk; Sensitivity and Specificity; Spinal Cord | 2007 |
Pathogenetic role of myelitis for syringomyelia.
Topics: Adult; Back Pain; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Multiple Sclerosis; Myelitis; Myelitis, Transverse; Neck Pain; Neurologic Examination; Neuromyelitis Optica; Paresthesia; Prednisone; Quadriplegia; Recurrence; Sarcoidosis; Spinal Cord; Syringomyelia | 2007 |
A case of anti-aquaporin-4 and anti-glutamate receptor antibodies positive myelitis presented with modest clinical signs.
Topics: Adult; Amnesia, Retrograde; Aquaporin 4; Autoantibodies; Biomarkers; Brain; Diagnosis, Differential; Female; Follow-Up Studies; Hashimoto Disease; Humans; Interferon-beta; Magnetic Resonance Imaging; Methylprednisolone; Neuromyelitis Optica; Neuroprotective Agents; Receptors, Glutamate; Spinal Cord | 2008 |
Reversible stenosis of large cerebral arteries in a patient with combined Sjögren's syndrome and neuromyelitis optica spectrum disorder.
Topics: Anti-Inflammatory Agents; Arterial Occlusive Diseases; Basilar Artery; Cerebral Arterial Diseases; Cerebral Arteries; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Magnetic Resonance Angiography; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Pulse Therapy, Drug; Sjogren's Syndrome | 2008 |
[Devic disease: a rare cause of retrobulbar optic neuritis: a case report].
Topics: Anti-Inflammatory Agents; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Optic Nerve; Optic Neuritis | 2000 |
Neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus: a case report.
Topics: Anti-Inflammatory Agents; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Vasculitis, Central Nervous System; Male; Methylprednisolone; Middle Aged; Neuromyelitis Optica; Plasmapheresis; Prednisolone; Treatment Outcome | 2002 |